Routine board expansion with no immediate trading catalyst. Monitor for any future committee assignments or strategic shifts, but no actionable signal from this filing alone.
Price Chart
Executive Summary
AbbVie expanded its Board of Directors from 12 to 13 members and appointed Dr. John M. Carethers as a Class II independent director. Dr. Carethers, Vice Chancellor for Health Sciences at UC San Diego and former Avantor director, joined the Public Policy and Sustainability Committee. This is a routine governance enhancement with no material financial impact.
Key Facts
- Board expanded from 12 to 13 directors
- Dr. John M. Carethers appointed as Class II independent director
- Dr. Carethers serves as Vice Chancellor for Health Sciences at UC San Diego
- Previously a director of Avantor, Inc.
- Appointed to the Public Policy and Sustainability Committee
- Determined independent under NYSE and AbbVie governance standards
Financial Impact
No financial figures disclosed; director compensation per existing independent director plan referenced in prior 10-Q
Risk Factors
- No material risks identified from this routine governance filing
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-116227 |
| Document: 0001104659-26-116227-index-headers.html | 0001104659-26-116227 |
| Document: 0001104659-26-116227-index.html | 0001104659-26-116227 |
| Document: 0001104659-26-116227.txt | 0001104659-26-116227 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | Institutional Cluster | $282.68 | awaiting T+60 | awaiting T+60 | $286.39 (+1.31%) |
Oct 15, 2026 12d ago | 8-K | $285.42 | awaiting T+60 | awaiting T+60 | $286.39 (+0.34%) |
Oct 5, 2026 22d ago | 8-K | $265.06 | awaiting T+60 | awaiting T+60 | $286.39 (+8.05%) |
Sep 28, 2026 4w ago | Court Ruling | $263.29 | awaiting T+60 | awaiting T+60 | $286.39 (+8.77%) |
Sep 14, 2026 6w ago | Court Ruling | $261.43 | awaiting T+60 | awaiting T+60 | $286.39 (+9.55%) |
Sep 3, 2026 7w ago | 8-K | $260.21 | awaiting T+60 | awaiting T+60 | $286.39 (+10.06%) |
Aug 5, 2026 11w ago | 8-K | $243.87 | awaiting T+60 | awaiting T+60 | $286.39 (+17.44%) |
Aug 2, 2026 12w ago | Institutional Cluster | $245.10 $286.97 | ▲ +17.08% | ▲ +15.30% | $286.39 (+16.85%) |
Aug 3, 2026 12w ago | Court Ruling | $243.80 | awaiting T+60 | awaiting T+60 | $286.39 (+17.47%) |
Jul 31, 2026 12w ago | 8-K | $250.94 $286.74 | ▲ +14.27% | ▲ +11.81% | $286.39 (+14.13%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers